Editas Medicine, Inc. (EDIT) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 2.83M | 24.74M | 7.54M | 3.58M | 4.66M | 30.6M | 61K | 513K | 1.14M | 60.05M | 5.34M | 2.89M |
| Revenue Growth % | -39.22% | -19.16% | 12265.57% | 597.47% | 310.4% | -49.04% | -98.86% | -82.23% | -88.48% | 818.74% | 12604.76% | -54.62% |
| Cost of Goods Sold | 483K | 0 | 0 | 0 | 0 | 0 | 1.6M | 1.42M | 1.41M | 1.47M | 1.51M | 29.78M |
| COGS % of Revenue | 17.06% | - | - | - | - | - | 2621.31% | 276.8% | 124.14% | 2.44% | 28.37% | 1031.49% |
| Gross Profit | 2.35M | 24.74M | 7.54M | 3.58M | 4.66M | 30.6M | -1.54M | -907K | -274K | 58.58M | 3.82M | -26.89M |
| Gross Margin % | 82.94% | 100% | 100% | 100% | 100% | 100% | -2521.31% | -176.8% | -24.14% | 97.56% | 71.63% | -931.49% |
| Gross Profit Growth % | -49.59% | -19.16% | 590.44% | 494.49% | 1800% | -47.76% | -140.24% | 96.63% | 99.02% | 228.86% | 109.26% | 27.9% |
| Operating Expenses | 27.35M | 38.76M | 32.09M | 55.12M | 80.82M | 77.2M | 64.13M | 71M | 66.72M | 82.55M | 53.98M | 17.2M |
| OpEx % of Revenue | 966.13% | 156.65% | 425.44% | 1540.58% | 1735.1% | 252.24% | 105127.87% | 13839.38% | 5878.15% | 137.46% | 1011.71% | 595.84% |
| Selling, General & Admin | 10.23M | 11.35M | 12.32M | 12.86M | 13.38M | 16.35M | 18.09M | 18.21M | 19.34M | 14.46M | 14.99M | 17.2M |
| SG&A % of Revenue | 361.5% | 45.89% | 163.28% | 359.39% | 287.14% | 53.44% | 29652.46% | 3548.93% | 1703.88% | 24.07% | 280.87% | 595.84% |
| Research & Development | 2.83M | 27.4M | 19.77M | 16.18M | 26.59M | 48.61M | 47.64M | 52.79M | 47.38M | 68.09M | 5.34M | 29.78M |
| R&D % of Revenue | 100% | 110.76% | 262.16% | 452.24% | 570.91% | 158.84% | 78096.72% | 10290.45% | 4174.27% | 113.39% | 100% | 1031.49% |
| Other Operating Expenses | 1000K | 0 | 0 | 1000K | 1000K | 1000K | -1000K | 0 | 0 | 0 | 1000K | -1000K |
| Operating Income | -25M | -14.02M | -24.55M | -51.54M | -76.16M | -46.59M | -65.67M | -71.9M | -66.99M | -23.96M | -50.16M | -44.09M |
| Operating Margin % | -883.19% | -56.65% | -325.44% | -1440.58% | -1635.1% | -152.24% | -107649.18% | -14016.18% | -5902.29% | -39.9% | -940.09% | -1527.33% |
| Operating Income Growth % | 67.17% | 69.92% | 62.62% | 28.31% | -13.69% | -94.45% | -30.91% | -63.07% | -31.46% | 62.23% | 12.79% | 18.7% |
| EBITDA | -24.52M | -13.21M | -23.83M | -49.71M | -74.25M | -45.21M | -64.07M | -70.48M | -65.58M | -22.5M | -48.65M | -42.55M |
| EBITDA Margin % | -866.13% | -53.4% | -315.88% | -1389.32% | -1593.95% | -147.73% | -105027.87% | -13739.38% | -5778.15% | -37.46% | -911.71% | -1473.99% |
| EBITDA Growth % | 66.97% | 70.78% | 62.81% | 29.47% | -13.21% | -100.98% | -31.69% | -65.63% | -32.71% | 63.64% | 13% | 19.15% |
| D&A (Non-Cash Add-back) | 483K | 805K | 721K | 1.83M | 1.92M | 1.38M | 1.6M | 1.42M | 1.41M | 1.47M | 1.51M | 1.54M |
| EBIT | -25M | -6.08M | -22.72M | -51.22M | -73.87M | -34.36M | -62.14M | -71.9M | -66.99M | -23.96M | -50.16M | -44.09M |
| Net Interest Income | 134K | 1K | -568K | 67K | 500K | 1.2M | 3.53M | 4.3M | 5.04M | 5.1M | 5.14M | 3.81M |
| Interest Income | 1.21M | -6.63M | 1.83M | 2.09M | 2.72M | 1.2M | 3.53M | 4.3M | 5.04M | 5.1M | 5.14M | 3.81M |
| Interest Expense | 1.07M | -6.63M | 2.4M | 2.02M | 2.22M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 21K | 8.4M | -569K | -1.69M | 75K | 1.2M | 3.52M | 4.3M | 5.04M | 5.09M | 5.14M | 3.8M |
| Pretax Income | -24.98M | -5.62M | -25.12M | -53.23M | -76.09M | -45.4M | -62.14M | -67.61M | -61.95M | -18.87M | -45.02M | -40.29M |
| Pretax Margin % | -882.44% | -22.72% | -332.98% | -1487.84% | -1633.49% | -148.33% | -101870.49% | -13178.75% | -5458.15% | -31.43% | -843.68% | -1395.57% |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -24.98M | -5.62M | -25.12M | -53.23M | -76.09M | -45.4M | -62.14M | -67.61M | -61.95M | -18.87M | -45.02M | -40.29M |
| Net Margin % | -882.44% | -22.72% | -332.98% | -1487.84% | -1633.49% | -148.33% | -101870.49% | -13178.75% | -5458.15% | -31.43% | -843.68% | -1395.57% |
| Net Income Growth % | 67.17% | 87.62% | 59.58% | 21.26% | -22.82% | -140.52% | -38.03% | -67.8% | -26.34% | 68.93% | 19.21% | 24.63% |
| Net Income (Continuing) | -24.98M | -5.62M | -25.12M | -53.23M | -76.09M | -45.4M | -62.14M | -67.61M | -61.95M | -18.87M | -45.02M | -40.29M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.26 | -0.06 | -0.28 | -0.63 | -0.92 | -0.55 | -0.75 | -0.82 | -0.76 | -0.23 | -0.55 | -0.56 |
| EPS Growth % | 71.74% | 89.49% | 62.67% | 23.17% | -21.05% | -139.13% | -36.36% | -46.43% | -15.15% | 71.25% | 29.49% | 27.27% |
| EPS (Basic) | -0.26 | -0.06 | -0.28 | -0.63 | -0.92 | -0.55 | -0.75 | -0.82 | -0.76 | -0.23 | -0.55 | -0.56 |
| Diluted Shares Outstanding | 97.88M | 88.75M | 90.09M | 84.41M | 83.06M | 82.61M | 82.49M | 82.31M | 81.94M | 81.71M | 81.65M | 71.38M |
| Basic Shares Outstanding | 97.88M | 88.75M | 90.09M | 84.41M | 83.06M | 82.61M | 82.49M | 82.31M | 81.94M | 81.71M | 81.65M | 71.38M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |